Echtzeit-Aktienkurs AMPHION INNOVAT. LS -,01
Bid:
Ask:
Echtzeit-Chart der AMPHION INNOVAT. LS -,01 Aktie
Fundamentaldaten der AMPHION INNOVAT. LS -,01 Aktie
Income Statement: 10-Year-Summary
| Datum | Umsatz | EBIT | Gewinn | EPS | Dividende | KGV | KUV |
|---|---|---|---|---|---|---|---|
| 2017 [GBP] | -2,24 Mio. | 1,94 Mio. | 1,94 Mio. | 0,01 | - | - | - |
| 2016 [GBP] | 0,58 Mio. | -12,48 Mio. | -12,48 Mio. | -0,07 | - | - | - |
| 2015 [GBP] | 2,16 Mio. | 3,89 Mio. | 3,89 Mio. | 0,02 | - | - | - |
| 2014 [GBP] | 0,82 Mio. | -7,65 Mio. | -7,65 Mio. | -0,06 | - | - | - |
| Die Multiples wie die KGVs werden mit der Bilanzwährung und dem Kurs des ausgewählten Börsenplatzes berechnet. Wählen Sie den Börsenplatz mit der Bilanzwährung aus, damit die Multiples korrekt sind. Die fundamentalen Daten werden von Facunda geliefert; Multiples werden mit dem aktuellen Kurs berechnet. |
Profil der AMPHION INNOVAT. LS -,01 Aktie
Amphion Innovations plc is a principal investment firm specializing in both public and private early stage investments and spun out of universities and corporations. It does not invest in “speculative� technologies requiring long development timeframes or excessive capital investment. It invests in the medical, life sciences, and technology sectors with defensible core intellectual property, know-how and growth potential in very large markets of at least $1 billion in size together with corporations, governments, universities, and entrepreneurs. The firm typically invests in companies with broad-based, proprietary, platform technologies in the areas of pharmacogenomics, proteomics, nutriceuticals or wellness, diagnostics, medical products and related fields, leveraging advances in and the convergence of materials science and life science IT, particularly software technologies. It targets investments in companies based in both the United States and United Kingdom. The firm makes inv